(FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | 48 | |
Other cash income from operating activities | --48 | ---- |
Cash paid | -98.04%-923.24K | -466.19K |
Payments to suppliers for goods and services | -98.04%-923.24K | ---466.19K |
Direct interest paid | -900.62%-3.23K | ---323 |
Operating cash flow | -98.58%-926.42K | ---466.51K |
Investing cash flow | ||
Cash flow from continuing investing activities | 32.34%-1.91M | -2.82M |
Capital expenditure reported | 29.46%-1.91M | ---2.7M |
Net PPE purchase and sale | 98.07%-2.28K | ---118.43K |
Cash from discontinued investing activities | ||
Investing cash flow | 32.34%-1.91M | ---2.82M |
Financing cash flow | ||
Cash flow from continuing financing activities | -91.01%624.78K | 6.95M |
Net issuance payments of debt | ---- | --0 |
Net common stock issuance | -90.56%656.65K | --6.95M |
Net other financing activities | -1,128.60%-31.87K | ---2.59K |
Cash from discontinued financing activities | ||
Financing cash flow | -91.01%624.78K | --6.95M |
Net cash flow | ||
Beginning cash position | 3,664,146.00%3.66M | --100 |
Current changes in cash | -160.30%-2.21M | --3.66M |
End cash Position | -60.30%1.45M | --3.66M |
Free cash from | 13.75%-2.83M | ---3.29M |
Accounting Standards | US-GAAP | US-GAAP |
No Data